NCT02253095

Brief Summary

Randomized, double-blind, placebo controlled trial of a combined intervention of zinc, albendazole, and multiple micronutrients in improving environmental enteropathy in Malawian children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
253

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 1, 2014

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

June 3, 2015

Status Verified

June 1, 2015

Enrollment Period

6 months

First QC Date

September 26, 2014

Last Update Submit

June 2, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Dual Sugar Absorption Test

    lactulose-mannitol ratio in urine

    12 weeks

  • Dual Sugar Absorption Test

    lactulose-mannitol ratio in urine

    24 weeks

Secondary Outcomes (4)

  • Lactulose Excretion

    12 weeks

  • Lactulose Excretion

    24 weeks

  • Mannitol Excretion

    12 weeks

  • Mannitol Excretion

    24 weeks

Study Arms (2)

Multiple Intervention Arm

EXPERIMENTAL

single dose albendazole, two weeks of zinc, 24 weeks of multiple micronutrients

Drug: AlbendazoleDietary Supplement: ZincDietary Supplement: Multiple Micronutrient Supplement

Placebo

PLACEBO COMPARATOR

three placebos

Drug: Placebo

Interventions

Multiple Intervention Arm
ZincDIETARY_SUPPLEMENT
Multiple Intervention Arm
Multiple Intervention Arm
Placebo

Eligibility Criteria

Age12 Months - 35 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • children residing in catchment area of Limela, Machinga District, Malawi
  • aged 12-35 months
  • youngest eligible child in each household

You may not qualify if:

  • severe acute malnutrition
  • severe chronic illness
  • children unable to drink 20 mL of dual sugar solution
  • children in need of acute medical treatment for illness or injury at time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Limela Rural Site

Limela, Machinga Distric, Malawi

Location

Related Publications (1)

  • Wang AZ, Shulman RJ, Crocker AH, Thakwalakwa C, Maleta KM, Devaraj S, Manary MJ, Trehan I. A Combined Intervention of Zinc, Multiple Micronutrients, and Albendazole Does Not Ameliorate Environmental Enteric Dysfunction or Stunting in Rural Malawian Children in a Double-Blind Randomized Controlled Trial. J Nutr. 2017 Jan;147(1):97-103. doi: 10.3945/jn.116.237735. Epub 2016 Nov 2.

MeSH Terms

Interventions

AlbendazoleZinc

Intervention Hierarchy (Ancestors)

CarbamatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsBenzimidazolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsMetals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Study Officials

  • Mark J Manary, MD

    Washington University in St. Louis; University of Malawi

    PRINCIPAL INVESTIGATOR
  • Chrissie Thakwalakwa, PhD

    University of Malawi

    STUDY DIRECTOR
  • Indi Trehan, MD MPH DTM&H

    Washington University in St. Louis; University of Malawi

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2014

First Posted

October 1, 2014

Study Start

October 1, 2014

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

June 3, 2015

Record last verified: 2015-06

Locations